...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and evaluation of new coumarin-pyridine hybrids with promising anti-osteoporotic activities
【24h】

Synthesis and evaluation of new coumarin-pyridine hybrids with promising anti-osteoporotic activities

机译:具有良好抗骨质疏松活性的香豆素-吡啶新杂种的合成与评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Anti-osteoporotic effects of the newly synthesized coumarin-pyridine hybrids were evaluated in primary cultures of rat calvarial osteoblasts in vitro. Compounds 6a, i, j and k were potent in stimulating osteoblast differentiation and mineralization as assessed by the alkaline phosphatase production and alizarin red-S staining assay, respectively. These compounds were also found to be nontoxic in osteoblast cells as compared to the control group in an MTT assay. Furthermore, the effect of these compounds on the transcript levels of osteogenic genes revealed that the compound 6j robustly enhanced mineralization of the osteogenic genes in calvarial osteoblasts. In this context, compound 6j was selected as a potential lead for further structural optimization in the development of new anti-osteoporotic agents.
机译:在大鼠颅盖成骨细胞的原代培养中,评估了新合成的香豆素-吡啶杂化物的抗骨质疏松作用。如分别通过碱性磷酸酶产生和茜素红-S染色测定所评估的,化合物6a,i,j和k有效地刺激成骨细胞分化和矿化。与MTT测定法中的对照组相比,还发现这些化合物对成骨细胞无毒。此外,这些化合物对成骨基因转录水平的影响表明,化合物6j牢固地增强了颅骨成骨细胞中成骨基因的矿化作用。在这种情况下,选择化合物6j作为开发新抗骨质疏松剂的进一步结构优化的潜在先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号